Pfizer share price: what to expect from Q4 results

In this article we find out what we can expect from the upcoming Pfizer results, how they could affect the Pfizer share price as well as how to trade the earnings.

When is Pfizer’s earnings date?

The Pfizer earnings release date is scheduled for the 2 February 2021. The results will cover the groups fourth quarter (Q4) and full year earnings.

Pfizer results preview: what does the Street expect?

Consensus estimates for Pfizer’s fiscal year 2020 (FY20) revenue, profit and earnings per share (EPS) values find confluence with the lower end of the company’s guidance in the last quarter. The forecasted range for the group's FY20 revenue is between $48.8 and $49.5 billion, a decline from the FY19 revenue figure of $51.75 billion. The FY20 EPS (adjusted and diluted) figure for Pfizer is expected to be realised at between $2.88 to $2.93, from $2.95 realised in the previous year (FY19).

How to trade Pfizer Q4 results

The two graphics below provide traders with both a retail short term view on the stock, as well as an institutional longer-term view on the Pfizer share price, as to how market participants are positioned ahead of the Q4 earnings release.

A Thomson Reuters poll of 21 analysts maintain a long-term average rating of ‘hold’ for Pfizer (as of 1 February 2021), with one of these analysts recommending a strong buy, five recommending a buy, 14 hold, one sell and zero strong sell recommendations on the stock.

From a retail trader perspective (as of 1 February 2021), 99% of IG clients with open positions on the Pfizer expect the share price to rise over the near term, while 1% of IG Clients with open positions expect the Pfizer price to fall.

Pfizer share price: technical analysis

The Pfizer share price continues to trade in a rangebound environment which has been in place since July last year (2020). This technical trading range is considered between levels 35.20 (support) and 39.30 (resistance).

In the short term, we see the Pfizer share price now approaching the support of the aforementioned range at 35.20. Range traders might hope for a bullish price reversal at or near this level to find long entry, targeting a move back towards historical resistance at 39.30. Should the share price instead continue to fall and trade below the 33.40 level, the rangebound price environment would require reassessment.

In summary

  • Pfizer Q4 results are scheduled for release on the 2 February
  • Group revenue and EPS for FY20 are expected to have declined from the previous year
  • The average long-term broker rating for Pfizer is ‘hold’
  • The majority of IG clients with open positions on Pfizer expect the price to rise in the near term
  • A technical analysis view on the Pfizer share price shows a short- to medium-term rangebound price environment

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

Please see important Research Disclaimer.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.